Literature DB >> 4933318

Evidence for immune complexes containing antibody to the pepsin site of IgG in rheumatoid synovial fluids.

O J Mellbye, J B Natvig.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4933318      PMCID: PMC1713037     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  29 in total

1.  Presence of aggregated gamma-G-globulin in certain rheumatoid synovial effusions.

Authors:  K Hannestad
Journal:  Clin Exp Immunol       Date:  1967-07       Impact factor: 4.330

2.  Heterogeneity of anti-gamma-globulin factors detected by pepsin-digested human gamma G-globulin.

Authors:  J B Natvig
Journal:  Acta Pathol Microbiol Scand       Date:  1966

3.  Rheumatoid factor in synovial effusions: local production and consumption.

Authors:  K Hannestad; O J Mellbye
Journal:  Clin Exp Immunol       Date:  1967-07       Impact factor: 4.330

4.  Reversible agglutination of trypsinised red cells by normal human sera: identification of the agglutinating factor as a gamma-M-globulin.

Authors:  O J Mellbye
Journal:  Scand J Haematol       Date:  1965

5.  Specificity of antiglobulin factors in normal human serum reacting with enzyme digested gamma-G-globulin.

Authors:  L C Kormeier; J T Ing; W J Mandy
Journal:  J Immunol       Date:  1968-03       Impact factor: 5.422

6.  Immunofluorescent demonstration of an IgG-B1C complex in synovial lining cells of rheumatoid synovial membrane.

Authors:  T D Kinsella; J Baum; M Ziff
Journal:  Clin Exp Immunol       Date:  1969-02       Impact factor: 4.330

7.  Reactions of aggregated mercaptoethanol treated gamma globulin with rheumatoid factor--precipitin and complement fixation studies.

Authors:  N J Zvaifler; P Schur
Journal:  Arthritis Rheum       Date:  1968-08

8.  Studies on agglutination by macromolecular antibodies. I. Agglutination of rabbit erythrocytes by human sera.

Authors:  O Tönder; F Milgrom
Journal:  Vox Sang       Date:  1965 Nov-Dec       Impact factor: 2.144

9.  Macroglobulin rheumatoid factors directed toward buried antigenic sites of human gamma-globulins.

Authors:  L S Schoenfeld; W V Epstein
Journal:  Vox Sang       Date:  1965 Jul-Aug       Impact factor: 2.144

10.  Studies of human anti-gamma-globulin factors reacting with pepsin-digested gamma-globulins.

Authors:  T G Lawrence; R C Williams
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

View more
  10 in total

1.  Detection of IgG rheumatoid factor by concanavalin A treatment and complement fixation with IgG rheumatoid factor.

Authors:  K Tanimoto; T Moritoh; T Azuma; Y Horiuchi
Journal:  Ann Rheum Dis       Date:  1976-06       Impact factor: 19.103

Review 2.  Rheumatoid arthritis: review of searches for an infectious cause. Part II.

Authors:  E Wilkes; E S Meek
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 3.  Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis.

Authors:  Leendert A Trouw; Theo Rispens; Rene E M Toes
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

4.  Evading pre-existing anti-hinge antibody binding by hinge engineering.

Authors:  Hok Seon Kim; Ingrid Kim; Linda Zheng; Jean-Michel Vernes; Y Gloria Meng; Christoph Spiess
Journal:  MAbs       Date:  2016-08-09       Impact factor: 5.857

5.  Synovial fluid and peripheral blood immune complexes of patients with rheumatoid arthritis induce apoptosis in cytokine-activated chondrocytes.

Authors:  A J Schuerwegh; E J Dombrecht; W J Stevens; J F Van Offel; M M Kockx; C H Bridts; L S De Clerck
Journal:  Rheumatol Int       Date:  2007-04-03       Impact factor: 2.631

6.  Further studies of the adjuvant properties of homologous IgG split products: mode of action of F(ab')2 and related fragments.

Authors:  A J Kulberg; L M Bartova; D N Evnin
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

7.  Anti-Fab antibodies in humans. Predominance of minor immunoglobulin G subclasses in rheumatoid arthritis.

Authors:  J E Persselin; R H Stevens
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

8.  Granulocytic function after administration of pepsin treated human gammaglobulin.

Authors:  L Lindquist; C Jarstrand; P Lundbergh
Journal:  Infection       Date:  1978       Impact factor: 3.553

9.  Analysis of immune complexes in synovial effusions of patients with rheumatoid arthritis.

Authors:  D Male; I M Roitt; F C Hay
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

Review 10.  Cross-reactive and pre-existing antibodies to therapeutic antibodies--Effects on treatment and immunogenicity.

Authors:  Karin A van Schie; Gerrit-Jan Wolbink; Theo Rispens
Journal:  MAbs       Date:  2015       Impact factor: 5.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.